These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1301128)

  • 1. Methods for assessing quality of life in the cardiac arrhythmia suppression trial (CAST).
    Willund I; Gorkin L; Pawitan Y; Schron E; Schoenberger J; Jared LL; Shumaker S
    Qual Life Res; 1992 Jun; 1(3):187-201. PubMed ID: 1301128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moricizine and quality of life in the Cardiac Arrhythmia Suppression Trial II (CAST II).
    Brooks MM; Gorkin L; Schron EB; Wiklund I; Campion J; Ledingham RB
    Control Clin Trials; 1994 Dec; 15(6):437-49. PubMed ID: 7851106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of sociodemographic, clinical, and quality-of-life variables to adherence in the cardiac arrhythmia suppression trial.
    Schron EB; Brooks MM; Gorkin L; Kellen JC; Morris M; Campion J; Shumaker SA; Corum J
    Cardiovasc Nurs; 1996; 32(2):1-6. PubMed ID: 8697488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Events in the cardiac arrhythmia suppression trial: baseline predictors of mortality in placebo-treated patients.
    Capone RJ; Pawitan Y; el-Sherif N; Geraci TS; Handshaw K; Morganroth J; Schlant RC; Waldo AL
    J Am Coll Cardiol; 1991 Nov; 18(6):1434-8. PubMed ID: 1939943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Cardiac Arrhythmia Suppression Trial: first CAST ... then CAST-II.
    Greene HL; Roden DM; Katz RJ; Woosley RL; Salerno DM; Henthorn RW
    J Am Coll Cardiol; 1992 Apr; 19(5):894-8. PubMed ID: 1552108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translation and field testing of the family functioning, family health and social support questionnaire in Danish outpatients with heart failure.
    Østergaard B; Pedersen KS; Lauridsen J; Nørgaard B; Jeune B
    Scand J Caring Sci; 2018 Jun; 32(2):554-566. PubMed ID: 28881450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychological factors and survival in the cardiac arrhythmia suppression trial (CAST): a reexamination.
    Thomas SA; Friedmann E; Wimbush F; Schron E
    Am J Crit Care; 1997 Mar; 6(2):116-26. PubMed ID: 9172848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: psychometric testing in an open-label clinical trial.
    Mathias SD; Bussel JB; George JN; McMillan R; Okano GJ; Nichol JL
    Clin Ther; 2007 May; 29(5):950-962. PubMed ID: 17697914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Polish MacNew heart disease heath-related quality of life questionnaire: a validation study.
    Moryś JM; Höfer S; Rynkiewicz A; Oldridge NB
    Cardiol J; 2015; 22(5):541-50. PubMed ID: 26004936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the English Version of the HeartQoL Health-Related Quality of Life Questionnaire in Patients With Coronary Heart Disease.
    Oldridge N; Cho C; Thomas R; Low M; Höfer S
    J Cardiopulm Rehabil Prev; 2018 Mar; 38(2):92-99. PubMed ID: 28671935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The azimilide post-infarct survival evaluation (ALIVE) trial.
    Camm AJ; Karam R; Pratt CM
    Am J Cardiol; 1998 Mar; 81(6A):35D-39D. PubMed ID: 9537221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of baseline characteristics with the hazard of encainide, flecainide, and moricizine therapy in patients with myocardial infarction. A possible explanation for increased mortality in the Cardiac Arrhythmia Suppression Trial (CAST).
    Anderson JL; Platia EV; Hallstrom A; Henthorn RW; Buckingham TA; Carlson MD; Carson PE
    Circulation; 1994 Dec; 90(6):2843-52. PubMed ID: 7994829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of advancing age on the efficacy and side effects of antiarrhythmic drugs in post-myocardial infarction patients with ventricular arrhythmias. The CAST Investigators.
    Akiyama T; Pawitan Y; Campbell WB; Papa L; Barker AH; Rubbert P; Friedman L; Keller M; Josephson RA
    J Am Geriatr Soc; 1992 Jul; 40(7):666-72. PubMed ID: 1607582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric properties of HeartQoL, a core heart disease-specific health-related quality of life questionnaire, in Danish implantable cardioverter defibrillator recipients.
    Zangger G; Zwisler AD; Kikkenborg Berg S; Kristensen MS; Grønset CN; Uddin J; Pedersen SS; Oldridge NB; Thygesen LC
    Eur J Prev Cardiol; 2018 Jan; 25(2):142-149. PubMed ID: 28952795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of an arrhythmia-specific scale in tachycardia and arrhythmia with focus on health-related quality of life.
    Ulla W; Anna S; Årestedt K
    J Cardiovasc Nurs; 2015; 30(2):98-108. PubMed ID: 24763354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HeartQoL: part II. Validation of a new core health-related quality of life questionnaire for patients with ischemic heart disease.
    Oldridge N; Höfer S; McGee H; Conroy R; Doyle F; Saner H;
    Eur J Prev Cardiol; 2014 Jan; 21(1):98-106. PubMed ID: 22822180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a secondary peak in myocardial infarction onset 11 to 12 hours after awakening: the Cardiac Arrhythmia Suppression Trial (CAST) experience.
    Peters RW; Zoble RG; Liebson PR; Pawitan Y; Brooks MM; Proschan M
    J Am Coll Cardiol; 1993 Oct; 22(4):998-1003. PubMed ID: 8409074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiff cardiac ablation patient-reported outcome measure (C-CAP): validation of a new questionnaire set for patients undergoing catheter ablation for cardiac arrhythmias in the UK.
    White J; Withers KL; Lencioni M; Carolan-Rees G; Wilkes AR; Wood KA; Patrick H; Cunningham D; Griffith M
    Qual Life Res; 2016 Jun; 25(6):1571-83. PubMed ID: 26659900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The MacNew Heart Disease Health-Related Quality of Life Questionnaire in patients with angina and patients with ischemic heart failure.
    Höfer S; Saleem A; Stone J; Thomas R; Tulloch H; Oldridge N
    Value Health; 2012 Jan; 15(1):143-50. PubMed ID: 22264982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can antiarrhythmic drugs survive survival trials?
    Pratt CM; Waldo AL; Camm AJ
    Am J Cardiol; 1998 Mar; 81(6A):24D-34D. PubMed ID: 9537220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.